Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Guardant Health Inc GH

Healthcare
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer... see more

Recent & Breaking News (NDAQ:GH)

Steve E. Krognes Joins Guardant Health Board of Directors

Business Wire July 7, 2022

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

PR Newswire July 6, 2022

Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

Business Wire June 13, 2022

Guardant Health to Participate in Upcoming June Investor Conferences

Business Wire May 26, 2022

First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d'Hebron Institute of Oncology

Business Wire May 25, 2022

Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Business Wire May 23, 2022

Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022

Business Wire May 21, 2022

Guardant Health Reports First Quarter 2022 Financial Results

Business Wire May 5, 2022

Guardant Health Announces Shield(TM) Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults

Business Wire May 2, 2022

Guardant Health to Participate in the BofA Securities 2022 Healthcare Conference

Business Wire April 28, 2022

Guardant Health to Report First Quarter Financial Results on May 5, 2022

Business Wire April 13, 2022

Guardant Health Presents New Data Showing Blood Test Highly Accurate in Detecting Multiple Cancers at the American Association for Cancer Research Annual Meeting

Business Wire April 11, 2022

Guardant Health Announces Partnership with Epic to Streamline Access to Company's Broad Portfolio of Cancer Tests

Business Wire April 4, 2022

Guardant Health Response to Frivolous and Retaliatory Lawsuit Filed by Illumina

Business Wire March 17, 2022

Guardant Health Receives Regulatory Approval for Guardant360® CDx in Japan

Business Wire March 14, 2022

Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at the American Association for Cancer Research Annual Meeting

Business Wire March 9, 2022

Guardant Health Receives Medicare Coverage for Guardant360 TissueNext(TM) Test

Business Wire March 8, 2022

Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook

Business Wire February 23, 2022

Guardant Health to Participate in Upcoming Investor Conferences

Business Wire February 7, 2022

Guardant Health to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

Business Wire February 1, 2022